(NYSE: STE) Steris's forecast annual revenue growth rate of 4.48% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.16%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10%.
Steris's revenue in 2024 is $5,407,384,000.On average, 2 Wall Street analysts forecast STE's revenue for 2025 to be $541,182,631,793, with the lowest STE revenue forecast at $539,253,781,830, and the highest STE revenue forecast at $543,111,580,571. On average, 3 Wall Street analysts forecast STE's revenue for 2026 to be $583,913,279,018, with the lowest STE revenue forecast at $569,010,047,446, and the highest STE revenue forecast at $605,280,430,691.
In 2027, STE is forecast to generate $599,980,144,667 in revenue, with the lowest revenue forecast at $599,980,144,667 and the highest revenue forecast at $599,980,144,667.